Sugi Predict

Sugi Predict / Compounds / SCHEMBL1984503

SCHEMBL1984503

SCHEMBL1984503

CC(=O)O[C@@H]1[C@@H](O)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@H](CO)[C@H]1O

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 5/20 0.52
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ CD69 Q07108 1/20 0.45
▸ PTPN1 P18031 2/20 0.45
▸ SLC28A3 Q9HAS3 2/20 0.44
▸ LGALS3 P17931 1/20 0.44
▸ LGALS4 P56470 1/20 0.44
▸ IGF2R P11717 1/20 0.43
▸ SELE P16581 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ FGF1 P05230 1/20 0.43
▸ FGF2 P09038 1/20 0.43
▸ VEGFA P15692 1/20 0.43
▸ HPSE Q9Y251 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1984501 0.91 CD69 (0.48) LGALS8MEN1KMT2ACD69PTPN1
SCHEMBL1522099 0.88 LGALS8 (0.43) LGALS8MEN1KMT2ACD69PTPN1
SCHEMBL17539017 0.87 LGALS8 (0.57) LGALS8CD69PTPN1SLC28A3LGALS3
SCHEMBL23381012 0.87 MEN1 (0.48) LGALS8MEN1KMT2APTPN1SLC28A3
SCHEMBL4103172 0.86 LGALS8 (0.52) LGALS8MEN1KMT2APTPN1LGALS3
SCHEMBL24495028 0.86 LGALS8 (0.48) LGALS8MEN1KMT2APTPN1SLC28A3
SCHEMBL24495271 0.86 LGALS8 (0.48) LGALS8MEN1KMT2ACD69PTPN1
SCHEMBL15518255 0.85 LGALS8 (0.56) LGALS8MEN1KMT2APTPN1LGALS3
SCHEMBL29220914 0.84 LGALS8 (0.71) LGALS8CD69PTPN1LGALS3
SCHEMBL2237219 0.84 LGALS8 (0.49) LGALS8CD69PTPN1LGALS3LGALS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116410901-B Preparation method and application of bifidobacterium longum freeze-dried powder 赣州京善科技合伙企业(有限合伙) 2024-02-06 — — CN claimed
CN-116410901-A Preparation method and application of bifidobacterium longum freeze-dried powder 赣州京善科技合伙企业(有限合伙) 2023-07-11 — — CN claimed
CN-116410901-B Preparation method and application of bifidobacterium longum freeze-dried powder 赣州京善科技合伙企业(有限合伙) 2024-02-06 — — CN disclosed
CN-117467127-A Polymer derivative with adjuvant effect and preparation method and application thereof 微缔医药科技(杭州)有限公司 2024-01-30 — — CN disclosed
CN-116410901-A Preparation method and application of bifidobacterium longum freeze-dried powder 赣州京善科技合伙企业(有限合伙) 2023-07-11 — — CN disclosed
CN-115501172-A Gel formulations for topical drug delivery 丹麦技术大学 2022-12-23 — — CN disclosed
CN-107249570-B Gel formulations for topical drug delivery 丹麦技术大学 2022-08-09 — — CN disclosed
US-10899879-B2 Biodegradable trehalose glycopolymers THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-01-26 — — US disclosed
EP-3180023-B1 BIODEGRADABLE TREHALOSE GLYCOPOLYMERS UNIV CALIFORNIA (US) 2020-02-19 — — EP disclosed
US-10273333-B2 Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-04-30 — — US disclosed
US-20180312630-A1 BIODEGRADABLE TREHALOSE GLYCOPOLYMERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-11-01 — — US disclosed
WO-2005053717-A1 STABILISATION OF VIRAL MICROPARTICLES QUADRANT DRUG DELIVERY LIMITED (GB) 2005-06-16 — — WO disclosed
EP-0994887-B1 MODIFIED GLYCOSIDES, COMPOSITIONS COMPRISED THEREOF AND METHODS OF USE THEREOF ELAN DRUG DELIVERY LTD (GB) 2002-11-27 — — EP disclosed
EP-0714905-B1 Process for producing trehalose derivatives HAYASHIBARA BIOCHEM LAB (JP) 2002-04-03 — — EP disclosed
US-20020009464-A1 Modified glycosides, compositions comprised thereof and methods of use thereof ELAN DRUG DELIVERY LTD. (GB) 2002-01-24 — — US disclosed
JP-2000204013-A MAKE-UP COSMETIC WITHOUT DRYNESS POLA CHEM IND INC 2000-07-25 — — JP disclosed
EP-0994887-A2 MODIFIED GLYCOSIDES, COMPOSITIONS COMPRISED THEREOF AND METHODS OF USE THEREOF QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 2000-04-26 — — EP disclosed
US-5906924-A REACTING ANHYDROUS TREHALOSE UNDER ANHYDROUS CONDITIONS KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGUKU KENKYUJO (JP) 1999-05-25 — — US disclosed
WO-1999001463-A2 MODIFIED GLYCOSIDES, COMPOSITIONS COMPRISED THEREOF AND METHODS OF USE THEREOF QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 1999-01-14 — — WO disclosed
EP-0714905-A2 Process for producing trehalose derivatives KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1996-06-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10899879-B2 Biodegradable trehalose glycopolymers TREH, B3GAT3, MGAM LGALS8 90/4885MEN1 2102/4885KMT2A 4452/4885
US-10273333-B2 Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization TREH, MGAM, TRRAP LGALS8 411/4885MEN1 3188/4885KMT2A 3638/4885
US-20180312630-A1 BIODEGRADABLE TREHALOSE GLYCOPOLYMERS TREH, B3GAT3, MGAM LGALS8 90/4885MEN1 1883/4885KMT2A 4503/4885
US-20020009464-A1 Modified glycosides, compositions comprised thereof and methods of use thereof PYGM, GCG, PYGL LGALS8 88/4885MEN1 1665/4885KMT2A 2886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback